High versus low dose cisplatin in epithelial ovarian cancer

Lancet. 1992 Sep 12;340(8820):678-9. doi: 10.1016/0140-6736(92)92221-z.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Carcinoma / drug therapy*
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin